Dow, Inc. (DOW)

40.09
0.97 2.40
NYSE
Prev Close 41.06
Open 41.22
Day Low/High 40.08 / 41.24
52 Wk Low/High 21.95 / 56.25
Volume 5.08M
Exchange NYSE
Shares Outstanding 741.12B
Market Cap 30.93B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Regulatory issues will weigh on this deal, because of populist politics.

Cramer: Takeover Talks Drown Out Earnings Reports

Cramer: Takeover Talks Drown Out Earnings Reports

Prospective deals are hijacking an earnings-based focus on fundamentals.

Cramer: What a Democratic Sweep Would Mean for Stocks

Cramer: What a Democratic Sweep Would Mean for Stocks

For starters, trouble for banks, drugs, energy and M&A.

Dow Chemical Shares Spike After EU Resumes Evaluation

Dow Chemical Shares Spike After EU Resumes Evaluation

Dow Chemical rose more than 10% Monday after EU officials resumed their investigation into the company's proposed $130 million merger with DuPont.

My Takeaways and Observations (Early Edition)

Staying real, being transparent and honest. I made an important tactical move this afternoon -- close to the day's low. Talking Deutsche Bank in my Diary and in Barron's, I expect a capital raise (possibly rights offering, after a DOJ settlement).  ...

Trending Tickers: NFLX, TSLA, TASR, DOW

Trending Tickers: NFLX, TSLA, TASR, DOW

Tesla shares rise after the company reports a record number of quarterly deliveries.

EU News Should Goose DuPont

I suspect DuPont shares will trade a bit better in the near term after news that a timetable has been established in the restart of the European Union review of its planned merger with Dow Chemical . DuPont remains my favorite large-capitalization l...

Jim Cramer: EU May Not Approve the Dow-Dupont Merger

Jim Cramer: EU May Not Approve the Dow-Dupont Merger

Jim Cramer is skeptical the Dow Chemical merger with DuPont will be approved by regulators.

Morning Movers: AAPL, DOW, DD, RH, MFRM

Morning Movers: AAPL, DOW, DD, RH, MFRM

Dow Chemical and Dupont's proposed merger could face regulatory hurdles in Europe as regulators paused their review of the deal due to insufficient information provided by the companies.

Monsanto Wants Bayer Bid Security, but That Won't Stop a Regulatory Kibosh

Monsanto Wants Bayer Bid Security, but That Won't Stop a Regulatory Kibosh

Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.

Dow and DuPont Deal Could Be in Trouble

Dow and DuPont Deal Could Be in Trouble

The proposed merger between Dow Chemical and DuPont could be in jeopardy.

Dow Deal Could Be in Health-Care Hotseat

Dow Deal Could Be in Health-Care Hotseat

But even if Dow/DuPont merger fails, Dow is in good stead.

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.

Cramer: The Answer to This Market: Part 2

Cramer: The Answer to This Market: Part 2

I learned a long time ago, don’t outthink it.

My Takeaways and Observations

Bloomberg Radio, listen!  Bloomberg TV, watch!   I have a crush on Twitter .  Why the rally in retail may not be justified. Parts one and two and three. I am a buyer of Macy's down 10% (or so) from here.  I initiated a small J.C. Penney long.  I add...

Dow Chemical upgraded at JP Morgan

Jim Cramer: Second Quarter Earnings Provide Mixed Consumer Picture

Jim Cramer: Second Quarter Earnings Provide Mixed Consumer Picture

Second quarter earnings have been mixed so far, according to Jim Cramer.

Dow Chemical Beats Profit Forecasts, Delivers Big Productivity Savings

Dow Chemical Beats Profit Forecasts, Delivers Big Productivity Savings

A solid second quarter had Dow Chemical shares on the rise Thursday.

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Another heavy day on the earnings front kept investors busy.

Jim Cramer: Dow-Dupont Merger Approval Still in Question

Jim Cramer: Dow-Dupont Merger Approval Still in Question

It's unclear if the Dow Chemical and Dupont merger will take place, according to TheStreet's Jim Cramer.

Morning Movers: FB, SBMRY, F, DOW, GPRO

Morning Movers: FB, SBMRY, F, DOW, GPRO

Facebook crushes earnings expectations while SABMiller puts a hold on the AB InBev deal.

Cramer: Winners and Losers in the Earnings Game

Cramer: Winners and Losers in the Earnings Game

Good enough, tied with a good story, is pushing post-earnings bumps today.

DuPont Beats Earnings Ahead of Dow Chemical Merger

DuPont Beats Earnings Ahead of Dow Chemical Merger

DuPont shares were on the rise Tuesday following its latest quarterly results.

DOW Investor Mtg.

Midday Report: Dow Chemical Plans Job Cuts; U.S. Stocks Bounce Back

Midday Report: Dow Chemical Plans Job Cuts; U.S. Stocks Bounce Back

U.S. stocks recovered from a two-day selloff on Tuesday as the shock of the Brexit vote faded and hopes of further stimulus rose.

Dow Chemical downgraded at JP Morgan

Four Materials ETFs Set for a Strong Second Half

Four Materials ETFs Set for a Strong Second Half

The materials sector has been one of the S&P's leaders so far in 2016 with returns trailing only utilities and energy.

Cramer: We Need to See New Money Getting Into the Market

Cramer: We Need to See New Money Getting Into the Market

Without it, any rally would just be a short-covering bump. 

Today's Takeaways and Observations

I started the day with Apple (AAPL) as JPMorgan reduced the share price target from $125 to $105.    Then a sports metaphor and an interesting two-part opening missive on the markets -- here and here.  I got lucky and covered a bunch into the mornin...

Dow Chemical: Potential Reward Worth Risk

Dow Chemical: Potential Reward Worth Risk

Some anticipation may be needed on this stock to get the optimum risk-reward.